Pectin-adriamycin (Chongqing LUMMY Pharmaceutical)

N/A

Report date: 2025/01/26 17:44:32
NME

Base Information

Drug NamePectin-adriamycin (Chongqing LUMMY Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA intercalatorsDNA topoisomerase I inhibitors
TargetsDNA topoisomerase IDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChongqing Lummy Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Lummy Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A